Procedure Guidance

Percutaneous Gastrostomy (PEG & PUG) in the NeuroICU

Patients with acute neurological injury who cannot swallow safely require an alternative route for enteral nutrition. A percutaneous gastrostomy tube — placed endoscopically (PEG) or under ultrasound guidance (PUG) — provides durable, safe gastric access while avoiding the risks of prolonged nasogastric feeds.

PEG vs. PUG: What Is the Difference?

PEG (Percutaneous Endoscopic Gastrostomy) is placed using a flexible endoscope advanced into the stomach under IV sedation. The endoscopist transilluminates the anterior abdominal wall to guide percutaneous needle entry. PEG has a decades-long track record and is widely available.

PUG (Percutaneous Ultrasound-guided Gastrostomy) is a newer bedside technique in which real-time ultrasound replaces endoscopy to visualize the stomach, guide needle puncture, and place the tube. PUG can be performed by an intensivist at the ICU bedside without endoscopy equipment, enabling same-session placement with percutaneous tracheostomy.

Key advantage of PUG in the neuro-ICU: because PUG does not require general anesthesia or OR transport, it can be combined with percutaneous tracheostomy in a single bedside session by Day 5, reducing procedure-related risk and length of stay.

Indications for Gastrostomy Placement

Anticipated inability to resume oral nutrition for >4 weeks.
Neurogenic dysphagia with confirmed aspiration risk (FEES/VFSS or bedside swallow evaluation).
Depressed level of consciousness (GCS ≤8) with no anticipated early recovery of protective reflexes.
Failed or poorly tolerated nasogastric feeds (high residuals, recurrent displacement, patient agitation).
High-dose enteral nutrition requirement exceeding safe nasogastric delivery.

Timing in the NeuroICU

Traditionally, gastrostomy placement was deferred until the patient's neurological trajectory was clearer — often >14 days. Evidence supporting early intervention combined with the availability of bedside PUG has shifted practice toward earlier placement, particularly when combined with tracheostomy.

The CriticalMindAI pathway targets gastrostomy placement by Day 5 in VISAGE high-risk patients, in combination with tracheostomy. This timing reduces total procedural exposure and supports earlier transfer to rehabilitation facilities.

Contraindications

Coagulopathy uncorrected (INR >1.5, platelets <50,000)
Peritoneal dialysis (relative — discuss with nephrology)
Prior gastric surgery or anatomy preventing safe puncture
Active abdominal infection or ascites
Hemodynamic instability
Patient already expected to tolerate oral intake within 7–10 days

Post-Placement Management

Tube feeds typically started within 4 hours of uncomplicated placement.
Initial bolus or continuous feeding based on GI tolerance.
Daily site assessment for granulation tissue, leakage, or skin breakdown.
Stoma matures in 7–14 days; tube can then be changed to a low-profile (button) device if appropriate.